Skip to main content
Fig. 7 | BMC Cancer

Fig. 7

From: Screening antiproliferative drug for breast cancer from bisbenzylisoquinoline alkaloid tetrandrine and fangchinoline derivatives by targeting BLM helicase

Fig. 7

BLM expression in MDA-MB-435 cells induced by HJNO. a BLM mRNA expression in MDA-MB-435 cells induced by HJNO (optical density ratio). b BLM protein expression in MDA-MB-435 cells induced by HJNO. Note:1: MDA-MB-435 cells (HJNO 10 μmol/L). 2: MDA-MB-435 cells (HJNO 5 μmol/L). 3: MDA-MB-435 cells (HJNO 2.5 μmol/L). 4: MDA-MB-435 cells (HJNO 0 μmol/L). 5: HUVEC cells (HJNO 0 μmol/L). *P < 0.05, **P < 0.01, compared with MDA-MB-435 cells (HJNO 0 μmol/L); #P < 0.05, compared with HUVEC cells (HJNO 0 μmol/L)

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us